Ovulation Testing Kits Market Size & Share 2023 to 2032

Ovulation Testing Kits Market Size

Ovulation Testing Kits Market size was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032. Ovulation testing kits are diagnostic tools that help women, determine the most fertile days of their menstrual cycle by detecting the surge in hormones, which precedes ovulation.

The WHO estimates that polycystic ovary syndrome (PCOS) affects an estimated 8-13% of reproductive-aged women, and up to 70% of affected women remain undiagnosed. Therefore, the increasing prevalence of PCOS and hormonal disorders underscores the growing demand for accurate ovulation testing kits, enabling affected women to track their cycles and enhance their conception prospects.
 

Furthermore, with the burgeoning awareness surrounding in-vitro fertilization (IVF) services, an increasing number of couples are actively pursuing avenues to enhance their fertility. Thus, ovulation testing kits play a pivotal role in this journey, empowering individuals to meticulously time their fertility treatments and, in turn, heighten their prospects of achieving successful IVF.
 

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the ovulation testing kit market. With increased interest in home-based health monitoring, the rise of telemedicine and point of care testing,  estimated to reach 78.3 billion by 2032, women embraced these kits as a safe and convenient way to track their fertility during lockdown. The flexibility of remote work arrangements and the integration of digital health solutions further fuelled adoption of these diagnostics kits.
 

Ovulation Testing Kits Market Trends

A range of factors, including lifestyle changes, stress, and delayed childbearing, has led to an increase in fertility issues among women. For instance, according to the CDC data, in the U.S., approximately 11% of women of childbearing age experience infertility, and about 6% of married women aged 15 to 49 years face infertility. Thus, ovulation testing kits provide a cost-effective and non-invasive means of understanding one's fertility window, helping couples address these challenges and plan for pregnancy effectively.
 

• Furthermore, ovulation testing kits have evolved significantly in terms of accuracy and ease of use. Modern kits often utilize advanced technology, such as digital displays and connectivity with smartphone apps, making it more convenient for individuals to monitor their fertility window.
   
• For instance, Clearblue's advanced digital ovulation test offers digital results and smartphone app synchronization, enhancing fertility tracking accuracy and convenience. These advancements contribute to the market's growth by improving user experience and reliability.
   

Ovulation Testing Kits Market Analysis

The market by product is categorized into urine-based ovulation testing kits, saliva-based ovulation testing kits, and digital ovulation testing kits. The urine-based ovulation testing kits segment is bifurcated into test strip type, cassette type, and midstream type. This segment garnered USD 992 million revenue size in the year 2022.
 

• The dominance of the segment can be attributed to their user-friendliness, affordability, and wide availability. These kits are favored for their ease of use and convenience, offering accurate results for at-home users. They have gained trust over time and cater to a broad consumer base.
   
• Furthermore, accessibility to urine-based ovulation kits in pharmacies and online platforms have solidified their market position. Moreover, the privacy and convenience of at-home testing have further encouraged women to use them for fertility monitoring, contributing to the overall market expansion.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on distribution channel, the ovulation testing kits market is segmented into e-commerce, hypermarkets and supermarkets, pharmacies and drugstores, and other distribution channels. The pharmacies and drugstores segment accounted for over 41% business share in the year 2022.
 

• Pharmacies and drugstores dominate the distribution of ovulation testing kits, offering widespread accessibility, professional guidance from pharmacists, a variety of product options, and convenience.
   
• Moreover, their presence significantly contributes to market growth by providing broad consumer access, instilling trust, and offering diverse product selections.
   

U.S. ovulation testing kits market accounted for USD 672 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The U.S. has taken a commanding position in the market, primarily due to its high fertility awareness, robust healthcare infrastructure, consumer affluence, and effective marketing efforts. This dominance not only signifies strong demand but also propels market growth by serving as a hub for innovation and product development.
   
• Additionally, the competitive landscape encourages the expansion of product portfolios, offering a wider range of options to cater to diverse consumer preferences and needs. Thus, the U.S.'s leading position plays a pivotal role in the global expansion and evolution of the market.
   

Ovulation Testing Kits Market Share

The ovulation testing kits industry is fragmented, with key players including Swiss Precision Diagnostics GmbH, Wondfo, iProven and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in September 2023, Prega News, a leading pregnancy detection card brand in India, expanded its product line to include the Ova News Ovulation Detection Kit. This new addition aimed at expanding the product portfolio and enhance the company's revenue.
 

Some of the eminent market participants operating in the ovulation testing kits industry include:

• Swiss Precision Diagnostics GmbH (Clearblue)
• ClinicalGuard
• Wondfo
• AccuMed
• PREGMATE
• iProven
• Wellify (Piramal group)
• Femometer
• Proov
• Easy@Home Fertility
• Ro
• Fairhaven Health
• Prega News (Mankind pharma)

Ovulation Testing Kits Industry News:

• In August 2023, Clearblue expanded its product range with the introduction of the groundbreaking Clearblue menopause stage indicator, a pioneering solution for evaluating a woman's probable menopause phase based on her urine FSH levels, age, and menstrual history. This product launch was geared towards both enriching the company's product portfolio and boosting its revenue.
   
• In March 2020, Proov received the U.S. FDA approval for its at-home ovulation testing kit. This kit enables in determining the presence of progesterone metabolite PdG in urine of a female, thereby evaluating the ovulating period. Thus, easy accessibility to at-home ovulation testing kits will accelerate industry expansion.
   

Ovulation testing kits market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million and Units)

• Urine-based ovulation testing kits

• Test strip type
• Cassette type
• Midstream type

• Saliva-based ovulation testing kits
• Digital ovulation testing kits

By Distribution Channel, 2018 – 2032 (USD Million)

• E-commerce
• Hypermarkets and supermarkets
• Pharmacies and drugstores
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa